HRTZ6.12.17REOPEN

Company

HERON THERAPEUTICS, INC. /DE/

Filed

June 12, 2017

Accession Number

0000812295-17-000128

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →